The DOI matches its Crossref record.
Production of an Acellular Amniotic Membrane Matrix for Use in Tissue Engineering
Abstract
A clinical need exists for an immunologically compatible surgical patch with a wide range of uses including soft tissue replacement, body wall repair, cardiovascular applications, and as a wound dressing. This study aimed to produce an acellular matrix from human amniotic membrane for future assessment as a surgical patch and a delivery system for epithelial cells. A novel detergent-based protocol was modified to remove all cellular components from amnion to render it non-immunogenic. Amnion was harvested within 24 h after elective caesarean section (n = 12). One sample group remained fresh, whereas the other was treated with 0.03% (w/v) sodium dodecyl sulphate, with hypotonic buffer and protease inhibitors, nuclease treatment, and terminal sterilization, using peracetic acid (0.1% v/v). Fresh and treated amnion was analyzed histologically for the presence of cells, deoxyribonucleic acid (DNA), collagen, glycosaminoglycans (GAGs), and elastin. Quantitative analysis was performed to determine levels of GAGs, elastin, hydroxyproline, denatured collagen, and DNA. The biomechanical properties of the membrane were determined using uniaxial tensile testing to failure. Histological analysis of treated human amnion showed complete removal of cellular components from the tissue; the histoarchitecture remained intact. All major structural components of the matrix were retained, including collagen type IV and I, laminin, and fibronectin. Differences were observed between fresh and decellularized amnion in matrix hydroxyproline (34.7 microg/mg vs 49.7 microg/mg), GAG (42.5 microg/mg vs 85.4 microg/mg), denatured collagen (2.2 microg/mg vs 1.7 microg/mg), and elastin (359.2 microg/mg vs 490.8 microg/mg) content. DNA content was diminished after treatment. Acellular matrices were biocompatible, cells grew in contact, and there was no decrease in cell viability after incubation with soluble tissue extracts. In addition, no significant reduction in ultimate tensile strength, extensibility, or elasticity was found after decellularization. Removal of the cellular components should eliminate immunological rejection. The resulting matrix was biocompatible in vitro and exhibited no adverse effects on cell morphology or viability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Collagen-Based Biomaterials for Tissue Engineering Applications
Parenteau-Bareil, R., Gauvin, R., & Berthod, F. (2010) · Materials · doi:10.3390/ma3031863 · Cited by 1,256
Stem Cell Paracrine Actions and Tissue Regeneration
Baraniak, P. R., & McDevitt, T. C. (2010) · Regenerative Medicine · doi:10.2217/rme.09.74 · Cited by 843
Properties of the amniotic membrane for potential use in tissue engineering
Department of Nanomedicine and Tissue Engineering, S. B. M. U., Niknejad, H., Peirovi, H., Jorjani, M., Ahmadiani, A., Ghanavi, J., & Seifalian, A. (2008) · European Cells and Materials · doi:10.22203/ecm.v015a07 · Cited by 823
Kim, B. S., Das, S., Jang, J., & Cho, D.-W. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00808 · Cited by 465
Embryonic Stem Cells Proliferate and Differentiate when Seeded into Kidney Scaffolds
Ross, E. A., Williams, M. J., Hamazaki, T., Terada, N., Clapp, W. L., Adin, C., Ellison, G. W., Jorgensen, M., & Batich, C. D. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008111196 · Cited by 382
Decellularized Rhesus Monkey Kidney as a Three-Dimensional Scaffold for Renal Tissue Engineering
Nakayama, K. H., Batchelder, C. A., Lee, C. I., & Tarantal, A. F. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0602 · Cited by 359
Porzionato, A., Stocco, E., Barbon, S., Grandi, F., Macchi, V., & De Caro, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124117 · Cited by 319
Collagen—emerging collagen based therapies hit the patient
Abou Neel, E. A., Bozec, L., Knowles, J. C., Syed, O., Mudera, V., Day, R., & Hyun, J. K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.010 · Cited by 296
Decellularized matrices for tissue engineering
Hoshiba, T., Lu, H., Kawazoe, N., & Chen, G. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2010.534079 · Cited by 294
Cheng, N.-C., Estes, B. T., Awad, H. A., & Guilak, F. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2008.0253 · Cited by 290
Wilshaw, S.-P., Kearney, J., Fisher, J., & Ingham, E. (2008) · Tissue Engineering Part A · doi:10.1089/tea.2007.0145 · Cited by 137
Self-citationNovel Utilization of Serum in Tissue Decellularization
Gui, L., Chan, S. A., Breuer, C. K., & Niklason, L. E. (2010) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2009.0120 · Cited by 109
A sterilization method for decellularized xenogeneic cardiovascular scaffolds
Fidalgo, C., Iop, L., Sciro, M., Harder, M., Mavrilas, D., Korossis, S., Bagno, A., Palù, G., Aguiari, P., & Gerosa, G. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.11.035 · Cited by 71
Helliwell, J. A., Thomas, D. S., Papathanasiou, V., Homer-Vanniasinkam, S., Desai, A., Jennings, L. M., Rooney, P., Kearney, J. N., & Ingham, E. (2017) · Journal of Tissue Engineering · doi:10.1177/2041731417724011 · Cited by 21
Self-citationChen, X., Zhou, Y., Sun, Y., Ji, T., & Dai, H. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10400 · Cited by 21
Ganjibakhsh, M., Mehraein, F., Koruji, M., Aflatoonian, R., & Farzaneh, P. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111544 · Cited by 18
Fabrication of a multi-layered decellularized amniotic membranes as tissue engineering constructs
Yüksel, S., Aşık, M. D., Aydin, H. M., Tönük, E., Aydın, E. Y., & Bozkurt, M. (2022) · Tissue and Cell · doi:10.1016/j.tice.2021.101693 · Cited by 6
Metadata
- Authors
- Wilshaw, S.-P., Kearney, J. N., Fisher, J., & Ingham, E.
- Venue
- Tissue Engineering
- Publisher
- SAGE Publications
- Published
- 2006-08
- Volume
- 12
- Issue
- 8
- Pages
- 2117-2129
- ISSN
- 1076-3279 (ISSN-L)
- 1557-8690
- OpenAlex
- W2077597743
- Cited by
- 239
- References
- 0
- FWCI
- 7.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.